HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaifeng Lu Selected Research

cariprazine

1/2019Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.
11/2018Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
1/2018Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.
1/2018Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].
1/2018The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study.
1/2018Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
12/2017Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.
11/2017Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies.
1/2017Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study.
1/2017The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaifeng Lu Research Topics

Disease

12Schizophrenia (Dementia Praecox)
01/2019 - 08/2015
11Migraine Disorders (Migraine)
01/2022 - 11/2019
8Psychomotor Agitation (Akathisia)
11/2018 - 03/2015
7Mania (Manias)
01/2019 - 03/2015
4Headache (Headaches)
01/2021 - 12/2015
4Pain (Aches)
01/2021 - 11/2019
3Sleep Initiation and Maintenance Disorders (Insomnia)
11/2018 - 12/2015
3Tremor (Tremors)
08/2015 - 03/2015
3Weight Loss (Weight Reduction)
08/2009 - 08/2007
2Epilepsy (Aura)
01/2020 - 12/2019
2Nausea
12/2019 - 03/2015
2Constipation
11/2018 - 03/2015
2Body Weight (Weight, Body)
01/2018 - 11/2017
2Weight Gain
01/2018 - 08/2009
2Vomiting
01/2017 - 03/2015
2Basal Ganglia Diseases (Basal Ganglia Disease)
08/2015 - 03/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Appendicitis
12/2019
1Sleepiness
12/2019
1Spontaneous Abortion (Miscarriage)
12/2019
1Pericardial Effusion
12/2019
1Major Depressive Disorder (Major Depressive Disorders)
11/2018
1Fatigue
11/2018
1Arthralgia (Joint Pain)
11/2018
1Bipolar Disorder (Manic Depressive Psychosis)
01/2017
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2016
1Dyspepsia (Indigestion)
03/2015
1Obesity
01/2008
1Insulin Resistance
10/2006
1Hypoglycemia (Reactive Hypoglycemia)
10/2006
1Type 2 Diabetes Mellitus (MODY)
10/2006

Drug/Important Bio-Agent (IBA)

18cariprazineIBA
01/2019 - 03/2015
9Dopamine (Intropin)FDA LinkGeneric
01/2019 - 08/2015
8Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2022 - 11/2019
8ubrogepantIBA
01/2022 - 11/2019
5Antipsychotic Agents (Antipsychotics)IBA
01/2018 - 01/2016
3atogepantIBA
01/2022 - 01/2020
2Calcitonin Gene-Related PeptideIBA
01/2020 - 01/2020
2ProlactinIBA
01/2018 - 11/2017
2Pharmaceutical PreparationsIBA
11/2017 - 08/2009
1Tryptamines (Triptans)IBA
01/2020
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2020
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2020
1Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2020
1Sumatriptan (Imigran)FDA LinkGeneric
01/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2020
15-HT1A Serotonin ReceptorIBA
01/2019
1Antidepressive Agents (Antidepressants)IBA
11/2018
1Therapeutic UsesIBA
11/2016
1Aripiprazole (Abilify)FDA Link
12/2015
1N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA
01/2008
1CannabinoidsIBA
01/2008
1neuropeptide Y5 receptorIBA
08/2007
1trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA
08/2007
1Neuropeptide YIBA
08/2007
1Hormones (Hormone)IBA
08/2007
1Orlistat (Xenical)FDA Link
08/2007
1sibutramine (Meridia)FDA Link
08/2007
1Metformin (Glucophage)FDA LinkGeneric
10/2006
1Insulin (Novolin)FDA Link
10/2006
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2006
1ProinsulinIBA
10/2006
1Glucose (Dextrose)FDA LinkGeneric
10/2006
1Pioglitazone (Actos)FDA Link
10/2006
1Sitagliptin Phosphate (Januvia)FDA Link
10/2006
1LipidsIBA
10/2006

Therapy/Procedure

3Therapeutics
11/2016 - 10/2006
1Drug Therapy (Chemotherapy)
01/2017
1Secondary Prevention
10/2016
1Glycemic Control
10/2006